Cargando…

Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway

Background and Objective: Glucose fluctuation (GF) has been reported to induce renal injury and diabetic nephropathy (DN). However, the mechanism still remains ambiguous. Mitochondrial energy metabolism, especially aerobic glycolysis, has been a hotspot of DN research for decades. The activation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wei-long, Liu, Su, Li, Nan, Ye, Li-fang, Zha, Min, Li, Chang-yin, Zhao, Yue, Pu, Qiang, Bao, Jin-jing, Chen, Xing-jie, Yu, Jiang-yi, Pei, Ying-hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969708/
https://www.ncbi.nlm.nih.gov/pubmed/33748166
http://dx.doi.org/10.3389/fmed.2021.656086
_version_ 1783666279942455296
author Xu, Wei-long
Liu, Su
Li, Nan
Ye, Li-fang
Zha, Min
Li, Chang-yin
Zhao, Yue
Pu, Qiang
Bao, Jin-jing
Chen, Xing-jie
Yu, Jiang-yi
Pei, Ying-hao
author_facet Xu, Wei-long
Liu, Su
Li, Nan
Ye, Li-fang
Zha, Min
Li, Chang-yin
Zhao, Yue
Pu, Qiang
Bao, Jin-jing
Chen, Xing-jie
Yu, Jiang-yi
Pei, Ying-hao
author_sort Xu, Wei-long
collection PubMed
description Background and Objective: Glucose fluctuation (GF) has been reported to induce renal injury and diabetic nephropathy (DN). However, the mechanism still remains ambiguous. Mitochondrial energy metabolism, especially aerobic glycolysis, has been a hotspot of DN research for decades. The activation of HIF-1α/miR210/ISCU/FeS axis has provided a new explanation for aerobic glycolysis. Our previous studies indicated quercetin as a potential therapeutic drug for DN. This study aims to evaluate levels of aerobic glycolysis and repressive effect of quercetin via HIF-1α/miR210/ISCU/FeS axis in a cell model of GF. Methods: The mouse glomerular mesangial cells (MCs) were exposed in high or oscillating glucose with or without quercetin treatment. Cell viability was measured by CCK8 assay. Aerobic glycolysis flux was evaluated by lactate acid, pH activity of PFK. Apoptosis level was confirmed by Annexin V-APC/7-AAD double staining and activity of caspase-3. TNF-α and IL-1β were used to evaluate inflammation levels. Results: GF deteriorated inflammation damage and apoptosis injury in MCs, while quercetin could alleviate this GF-triggered cytotoxicity. GF intensified aerobic glycolysis in MCs and quercetin could inhibit this intensification in a dose-dependent manner. Quercetin prevented activities of two FeS-dependent metabolic enzymes, aconitase, and complex I, under GF injury in MCs. The mRNA expression and protein contents of HIF-1α were increased after GF exposure, and these could be alleviated by quercetin treatment. Knockdown of ISCU by siRNA and Up-regulating of miR-210 by mimic could weaken the effects of quercetin that maintained protein levels of ISCU1/2, improved cell viability, relieved inflammation injury, decreased apoptosis, and reduced aerobic glycolysis switch in MCs. Conclusion: Quercetin antagonizes GF-induced renal injury by suppressing aerobic glycolysis via HIF-1α/miR-210/ISCU/FeS pathway in MCs cell model. Our findings contribute to a new insight into understanding the mechanism of GF-induced renal injury and protective effects of quercetin.
format Online
Article
Text
id pubmed-7969708
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79697082021-03-19 Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway Xu, Wei-long Liu, Su Li, Nan Ye, Li-fang Zha, Min Li, Chang-yin Zhao, Yue Pu, Qiang Bao, Jin-jing Chen, Xing-jie Yu, Jiang-yi Pei, Ying-hao Front Med (Lausanne) Medicine Background and Objective: Glucose fluctuation (GF) has been reported to induce renal injury and diabetic nephropathy (DN). However, the mechanism still remains ambiguous. Mitochondrial energy metabolism, especially aerobic glycolysis, has been a hotspot of DN research for decades. The activation of HIF-1α/miR210/ISCU/FeS axis has provided a new explanation for aerobic glycolysis. Our previous studies indicated quercetin as a potential therapeutic drug for DN. This study aims to evaluate levels of aerobic glycolysis and repressive effect of quercetin via HIF-1α/miR210/ISCU/FeS axis in a cell model of GF. Methods: The mouse glomerular mesangial cells (MCs) were exposed in high or oscillating glucose with or without quercetin treatment. Cell viability was measured by CCK8 assay. Aerobic glycolysis flux was evaluated by lactate acid, pH activity of PFK. Apoptosis level was confirmed by Annexin V-APC/7-AAD double staining and activity of caspase-3. TNF-α and IL-1β were used to evaluate inflammation levels. Results: GF deteriorated inflammation damage and apoptosis injury in MCs, while quercetin could alleviate this GF-triggered cytotoxicity. GF intensified aerobic glycolysis in MCs and quercetin could inhibit this intensification in a dose-dependent manner. Quercetin prevented activities of two FeS-dependent metabolic enzymes, aconitase, and complex I, under GF injury in MCs. The mRNA expression and protein contents of HIF-1α were increased after GF exposure, and these could be alleviated by quercetin treatment. Knockdown of ISCU by siRNA and Up-regulating of miR-210 by mimic could weaken the effects of quercetin that maintained protein levels of ISCU1/2, improved cell viability, relieved inflammation injury, decreased apoptosis, and reduced aerobic glycolysis switch in MCs. Conclusion: Quercetin antagonizes GF-induced renal injury by suppressing aerobic glycolysis via HIF-1α/miR-210/ISCU/FeS pathway in MCs cell model. Our findings contribute to a new insight into understanding the mechanism of GF-induced renal injury and protective effects of quercetin. Frontiers Media S.A. 2021-03-04 /pmc/articles/PMC7969708/ /pubmed/33748166 http://dx.doi.org/10.3389/fmed.2021.656086 Text en Copyright © 2021 Xu, Liu, Li, Ye, Zha, Li, Zhao, Pu, Bao, Chen, Yu and Pei. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Xu, Wei-long
Liu, Su
Li, Nan
Ye, Li-fang
Zha, Min
Li, Chang-yin
Zhao, Yue
Pu, Qiang
Bao, Jin-jing
Chen, Xing-jie
Yu, Jiang-yi
Pei, Ying-hao
Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway
title Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway
title_full Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway
title_fullStr Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway
title_full_unstemmed Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway
title_short Quercetin Antagonizes Glucose Fluctuation Induced Renal Injury by Inhibiting Aerobic Glycolysis via HIF-1α/miR-210/ISCU/FeS Pathway
title_sort quercetin antagonizes glucose fluctuation induced renal injury by inhibiting aerobic glycolysis via hif-1α/mir-210/iscu/fes pathway
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969708/
https://www.ncbi.nlm.nih.gov/pubmed/33748166
http://dx.doi.org/10.3389/fmed.2021.656086
work_keys_str_mv AT xuweilong quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT liusu quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT linan quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT yelifang quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT zhamin quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT lichangyin quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT zhaoyue quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT puqiang quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT baojinjing quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT chenxingjie quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT yujiangyi quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway
AT peiyinghao quercetinantagonizesglucosefluctuationinducedrenalinjurybyinhibitingaerobicglycolysisviahif1amir210iscufespathway